DRUG DISCOVERY & DEVELOPMENT
WITH A BETTER ASSESSMENT
OF YOUR COMPOUNDS ON REGULATORY T CELLS

ABOUT US

Immune insighT is a Contract Research Organization (CRO) based In Lille (France) founded in 2016, Spin-off which stems from academic research.

We are specialized in ex-vivo and in-vivo assessment of compounds on the immune system and more specifically regulatory T cells (Tregs).

OUR SCIENCE

Molecular insight

An original Treg Molecular Signature (TregSign kit) which allows, in a single assay, a complete transcriptomic study of Tregs.
KNOW MORE

Cellular insight

A wide range of methods to comprehensively assess the efficacy and safety of your compound of interest on Treg Biology.
KNOW MORE

Animal insight

In vivo assessment of a compound efficacy and safety can be carried out on a human cancer model designed for you (Syngeneic, PDX-Like models…).
KNOW MORE

NEWS

December 2020

Immune insighT participated in the International Biofit conference on 7th – 10th December 2020

November 2020

Immune insighT is a proud sponsor of the PROVENTA INTERNATIONAL :
Online Oncology strategy Meeting (3rd November)
Come meet with us at the Proventa: Online Strategy Meeting.
We will be at the round table discussions surrounding ADCs and ICI in Oncology.

November 2020

To stay updated on all the latest trends in oncology treatments, Immune insighT attended to annual PhotoDynamic Therapy and Photo diagnosis E-congress 5th-6th November 2020.

previous arrow
next arrow
Slider

OUR PARTNERS

Scroll to Top